Dr. Civin is a pioneer in cancer and stem cell research who is known internationally for developing a way to isolate stem cells from other blood cells. He has received wide recognition for his groundbreaking discovery of the CD34 antibody, which has had a major impact on the field of blood cell research. Through his laboratory work, Dr. Civin accomplished the rare feat of making multiple discoveries that are used today not only in laboratory research but also in clinical bone marrow stem cell transplantation and leukemia diagnosis.
Dr. Civin holds many biomedical patents and is currently a principal of collaborating investigator on several peer-reviewed research projects funded by the National Institutes of Health, the state of Maryland Stem Cell Research Fund, the Leukemia & Lymphoma Society, the National Foundation for Cancer Research, and other private foundations. Dr. Civin taught and led research and clinical pediatric oncology and held the King Fahd Chair in Pediatric Oncology and the Herman & Walter Samuelson Chair in Cancer Research at Johns Hopkins University School of Medicine for 30 years before becoming founding director for the University of Maryland’s Center for Stem Cell Biology & Regenerative Medicine and Associate Dean for Research. He has lectured around the world, published more than 250 articles and book chapters, received many awards, and served in leadership positions of multiple distinguished committees and editorial boards. Throughout his career, he has mentored a large number of talented scientists to pursue academic careers in translational research.